Found 78 matching trials
Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer PHASE4 This pilot clinical trial studies how well endocrine therapy works in treat...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer PHASE2 This research study is evaluating a drug called Palbociclib in combination ...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis PHASE2 This phase II trial studies how well radiation therapy given with standard ...
Show More Location
Grady Health System
Learn More & Join Trial
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer PHASE1 This phase Ib trials studies the side effects and how well talimogene laher...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Pharmacology of Adjuvant Hormonotherapy in Breast Cancer PHASE4 This is a biomedical study of interventional type, multicenter, inter-regio...
Show More Learn More & Join Trial
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer PHASE2 This phase II trial tests the accuracy of functional imaging (FFNP)-positro...
Show More Location
Siteman Cancer Center at Washington University
Learn More & Join Trial
Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer PHASE2 Primary Objective:
To determine whether amcenestrant per overall survival ...
Show More Location
Alabama Oncology - St. Vincent's Birmingham- Site Number : 8400008
Learn More & Join Trial
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy N/A Hormone receptor-positive breast cancer accounts for about 70% of all breas...
Show More Location
Cancer Hospital Affiliated to Harbin Medical University
Learn More & Join Trial
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) PHASE3 This Phase III Trial evaluates whether breast conservation surgery and endo...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer PHASE3 POLAR is a phase III clinical trial, which will test the safety and efficac...
Show More Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Learn More & Join Trial